age and sex
[용어속성] Term
Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study
미국과 페루에서 SARS-CoV-2 감염에서 회복된 인구통계학적 및 임상적으로 다양한 개인에서 시간이 지남에 따라 항체 반응 중화: 코호트 연구
Research Article
[키워드] 293T/ACE2 cells
acute respiratory syndrome coronavirus
age
age and sex
analyses
Analysis
antibody
Antibody Response
applied
assigned
association
Asymptomatic
Birth
Blood
body mass
body mass index
Clinical characteristics
clinical manifestations
Clinical outcome
clinical outcomes
clinically
Cohort
cohort study
collected
Comorbidities
Comorbidity
convalescent
convalescent individual
convalescent individuals
coronavirus 2
coronavirus disease
Coronavirus disease 2019
correlation
COVID-19
death
declined
demographic and clinical characteristics
Demographic variables
demographics
diabete
diabetes
disease onset
disease severity
enrolled
Factors
help
heterogeneity
highlighting
Hispanic
hypertension
identify
immune defense
immune response
immune responses
Immunity
implementation
in some
include
individual
Infection
limitation
Linear regression
Male sex
medical history
mild illness
Multiple
Multiple linear regression
NAb
NAb responses
NAb titers
NAbs
nasal samples
natural history
Neutralizing antibodies
neutralizing antibody
Neutralizing antibody response
neutralizing antibody responses
not differ
observation
participant
peaked
Protective
pulmonary disease
Questionnaires
researcher
respiratory
response
responses
SARS-CoV-2
SARS-CoV-2 antibody response
SARS-COV-2 infection
SARS-CoV-2 spike protein
serum
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe coronavirus disease
Sex
smoking
Spike protein
survivorship
the United State
therapeutic strategy
Therapeutics
thought
titers
to define
Treatment
Trial registration
United States
Vaccine
Variation
variety
Viral load
virus
virus infection
were measured
white
[DOI] 10.1371/journal.pmed.1003868 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pmed.1003868 PMC 바로가기 [Article Type] Research Article
A cross-sectional follow up study to estimate seroprevalence of coronavirus disease 2019 in Kobe, Japan
일본 고베에서 2019년 코로나바이러스 질환의 혈청 유병률을 추정하기 위한 횡단면 추적 연구
Article
[키워드] 95% CI
95% confidence interval
Abbott
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
added
adjusted
age and sex
antibody
calculated
census
Chain Reaction
city
clinic
conducted
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
cross-sectional
cross-sectional study
False positive
Follow-up
identify
IgG
Immunoglobulin
Immunoglobulin G
Japan
Kobe
Patient
PCR
polymerase chain
polymerase chain reaction
positive
Prevalence
respiratory
SARS-CoV-2
Sensitivity and specificity
serologic testing
serology assay
serology assays
Seroprevalence
serum sample
serum samples
severe acute respiratory syndrome Coronavirus
Sex
spread of COVID-19
stratified
study period
true positive
true positives
validation study
[DOI] 10.1097/MD.0000000000028066 PMC 바로가기 [Article Type] Article
[DOI] 10.1097/MD.0000000000028066 PMC 바로가기 [Article Type] Article
The role of lovastatin in the attenuation of COVID-19
Research article
[키워드] acute respiratory distress
addition
age and sex
Anti-inflammatory
Anti-viral
ARDS
case-control study
Consequences
control group
COVID-19
COVID-19 patient
CRP
demonstrated
disease
evaluated
Evidence
Hospitalization
ICU
ICU Patients
IL-6
IL-8
immunomodulatory
indicated
Inflammation
Inflammatory response
intensive care
Lovastatin
mitigate
mortality rate
myocardial damage
parameters
pathogenesis of COVID-19
pathology
Patient
patients
patients with COVID-19
per day
protective effect
receiving
reduced
SARS-CoV-2
SARS-COV-2 infection
severity
significantly
statin
statistically significant
statistically significant difference
study group
syndrome
the cytokine storm
the patient
three group
Thrombotic complications
[DOI] 10.1016/j.intimp.2021.108192 [Article Type] Research article
[DOI] 10.1016/j.intimp.2021.108192 [Article Type] Research article
IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workers
SARS-CoV-2에 대한 IgG 항체는 붕괴하지만 의료 종사자 집단에서 백신 접종 후 4개월 동안 지속됨
Article
[키워드] age
age and sex
anti-SARS-CoV-2
antibody
Antibody decay
Antibody Response
boost
chemiluminescence
clinical trials
Cohort
correlated
COVID-19
CRO
defined
Efficacy
Follow-up
healthcare worker
identify
IgG
IgG antibodies
IgG antibody
IgG response
immune response
Immunity
Immunoglobulin G
induce
IQR
material
monitoring
mRNA vaccination
mRNA vaccine
mRNA-1273
National Cancer Institute
of BNT162b2
RBD IgG
reactive
SARS-CoV-2
subject
suggested
supported
vaccination
Vaccine
[DOI] 10.1016/j.cca.2021.10.035 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.cca.2021.10.035 PMC 바로가기 [Article Type] Article
Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality
Research Article
[키워드] Accuracy
acute respiratory syndrome
adjusted hazard ratio
age and sex
antibody-dependent cellular cytotoxicity
assessment
benefit
Cohort
cohorts
collected
coronavirus
COVID-19
COVID-19 mortality
cytokine
death
description
disease
elevated
feature
help
heterogeneity
identify
Immunoglobulin
independent
individuals
log-transformed
management
marker
Mortality
on mechanical ventilation
outcome
Patient
performed
plasma
Predictive
predictor
quantitation
Receptor binding
remained
robust
SARS-CoV-2
SARS-CoV-2 RNA
symptom onset
Therapies
tissue injury
Viral RNA
vRNA
[DOI] 10.1126/sciadv.abj5629 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1126/sciadv.abj5629 PMC 바로가기 [Article Type] Research Article
Clonal Hematopoiesis of Indeterminate Potential Is Associated with Increased Age-Independent Morbidity and Mortality in Patients with COVID-19- the Beyond DNA COVID-19 Project
Conference abstract
[키워드] accounted
affected
age
age and sex
allele
approved
assays
association
ASXL1
ATAC-seq
baseline
Blood
blueprint
carried
ChIP
clinically
collected
common
Comorbidities
comparable
Coverage
COVID-19
COVID-19 diagnosis
COVID-19 disease severity
COVID-19 patient
CRP
CRS
cytokine
cytokine levels
Cytokine release syndrome
Cytokines
database
death
defined
described
Detection limit
DNA
download
elevated
ELISA assay
entire cohort
figure
Fisher
Follow-up
funding
Genes
grade 3
group
had more
hazard
healthy individual
Hematopoiesis
Hospitalization
hypoxemic
hypoxic respiratory failure
identify
IL6
Increased
increased mortality
indeterminate
indicated
individuals
Infection
Inflammation
Inflammatory
inflammatory cascade
Inflammatory marker
IRB
male
Mayo Clinic
MCP-1
median
median age
mononuclear cell
morbidity
Mortality
MPL
Mutation
mutations
neutropenia
no difference
observé
Older
pathophysiology
Patient
patients
patients with COVID-19
PBMC
Peripheral blood
Potential
proteomic study
reached
regression models
remained
Research
resolved
Respiratory failure
RNA
scale
Sequencing
severe disease
severity
Sex
SF3B1
Single Cell
ssDNA
subsequent
survival
survival analysis
TET2
the Kaplan-Meier method
the WHO
TNF-a
TP53
two groups
variables
variant
was performed
WHO
Wilcoxon rank sum
with COVID-19
[DOI] 10.1182/blood-2021-151548 [Article Type] Conference abstract
[DOI] 10.1182/blood-2021-151548 [Article Type] Conference abstract
The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population
Medicine
[키워드] MUC5B
acute respiratory syndrome
age and sex
aging lung
Analysis
Associate
association
candidate gene
Case-control
case-control study
Cohort
cohorts
comparable
confounding variable
Control
coronavirus
COVID-19
died
Diversity
European
Evidence
expressing
expression level
Frequency
Genotype
GWAS
Hospitalization
ICU
Idiopathic pulmonary fibrosis
innate immune response
Innate immunity
investigated
IPF
Italian
Italy
lung
Lung disease
male
median age
MUC5B
Mucus
non-infectious
Patient
polymorphism
Population
promoter
provide
pulmonary fibrosis
recruited
replicated
Replication
retrospective
risk allele
SARS-CoV-2
severe COVID-19
significantly
significantly lower
Spain
Spanish
trade-off
was performed
was used
while
with COVID-19
[DOI] 10.3389/fmed.2021.668024 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.668024 PMC 바로가기 [Article Type] Medicine
Clinical and Laboratory Factors in Predicting Mortality Among COVID-19 RT-PCR Positive Patients: A Retrospective Observational Study From a Tertiary Care Center
Internal Medicine
[키워드] Acute kidney injury
acute respiratory distress
acute respiratory distress syndrome [ards]
addition
age
age and sex
AKI
albumin
analyzed
Aspartate aminotransferase
AST
C-reactive protein (CRP
Cardiac arrest
carried
categorical variable
cause
center
clinical
clinical and laboratory characteristics
co-morbidities
co-morbidity
complications
condition
control group
coronavirus disease
coronavirus disease (COVID-19)
Corticosteroids
COVID-19
COVID-19 infection
CRP
D-dimer
death
diabetes
Factor
Frequency
Gender
higher odds
hypertensive
IL-6
independent risk factor
information
Intervention
laboratory parameter
lactate dehydrogenase
LDH
Lymphocytes
lymphopenia
mechanically ventilated
medical records
Monocytes
Mortality
Mortality predictors
multivariable logistic regression
nasal
neurological
Neutrophils
non-survivor
outcome
Oxygen therapy
patients with COVID-19
positive COVID-19
Prevent
procalcitonin
raised
Randomly
Result
retrospective
risk factor
risk stratification
RT-PCR
selected
serum creatinine
severity
shown
significantly
statistically
survivor
syndrome
Tertiary
Tocilizumab
univariable
was collected
were expressed
were used
[DOI] 10.7759/cureus.19791 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.19791 PMC 바로가기 [Article Type] Internal Medicine
Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection
Research Article
[키워드] Activation
adjusted
age and sex
Angiotensin II
association
auto-antibody
autoantibody
Coagulopathy
Comorbidity
controls
Coronavirus disease 2019
COVID-19
COVID-19 case
COVID-19 disease severity
diabetes
disease
endothelial
hypertension
individual
Logistic
median
Mild
negative control
not differ
pathology
Prevalence
pro-thrombotic
receptor
Result
SARS-COV-2 infection
severe COVID-19
severe disease
significantly higher
Support
type I
Vascular
[DOI] 10.1371/journal.pone.0259902 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0259902 PMC 바로가기 [Article Type] Research Article